期刊文献+

Characterization of focal hepatic lesions with contrast-enhanced C-cube gray scale ultrasonography 被引量:8

Characterization of focal hepatic lesions with contrast-enhanced C-cube gray scale ultrasonography
下载PDF
导出
摘要 AIM: To characterize enhancement patterns of focal hepatic lesions using C-cube gray scale sonography with a microbubble contrast agent and to evaluate its usefulness in differential diagnosis of hepatic lesions.METHODS: Fifty-four patients with 58 focal hepatic lesions were examined with Levovist-enhanced C-cube gray scale sonography. The final diagnosis of hepatic lesions was 29primary liver cancers, 4 metastases, 8 hemangiomas, 12focal nodular hyperplasias, 2 inflammatory pseudotumors of the liver and 3 angiomyolipomas. The initiation time of enhancement in various lesions and enhancement duration after administration of contrast agent were compared.Vascular findings in lesions were classified as peripheral enhancement, homogenous enhancement, mosaic enhancement and no enhancement depending on microbubble signals in the lesion relative to the liver parenchyma.RESULTS: The initiation time of enhancement in hemangioma (48±12 s) was significantly later compared to other lesions (P<0.05). The enhancement duration of malignancies (69±33 s in primary liver cancer, 61±23 s in metastasis) was significantly shorter compared to benign lesions (P<0.05).Intranodular enhancement appearing at arterial phase and decreasing at portal venous phase was considered characteristic for malignancy. Intranodular enhancement did not appear earlier than the liver parenchyma, and peripheral enhancement pattern was regarded as positive findings for hemangioma. Intranodular enhancement appeared in the arterial phase, and homogenous enhancement pattern sustained in the whole portal venous phase were regarded as positive findings for focal nodular hyperplasia. No microbubble signals appeared in two inflammatory pseudotumors of the liver.CONCLUSION: C-cube gray scale sonography can demonstrate dynamic intranodular enhancement in various focal hepatic lesions. The information provided by this methodology may be useful in the differential diagnosis of hepatic lesions. AIM: To characterize enhancement patterns of focal hepatic lesions using C-cube gray scale sonography with a microbubble contrast agent and to evaluate its usefulness in differential diagnosis of hepatic lesions.METHODS: Fifty-four patients with 58 focal hepatic lesions were examined with Levovist-enhanced C-cube gray scale sonography. The final diagnosis of hepatic lesions was 29 primary liver cancers, 4 metastases, 8 hemangiomas, 12 focal nodular hyperplasias, 2 inflammatory pseudotumors of the liver and 3 angiomyolipomas. The initiation time of enhancement in various lesions and enhancement duration after administration of contrast agent were compared. Vascular findings in lesions were classified as peripheral enhancement, homogenous enhancement, mosaic enhancement and no enhancement depending on microbubble signals in the lesion relative to the liver parenchyma.RESULTS: The initiation time of enhancement in hemangioma (48 ± 12 s) was significantly later compared to other lesions (P < 0.05). The enhancement duration of malignancies (69 ± 33 s in primary liver cancer, 61 ± 23 s in metastasis) was significantly shorter compared to benign lesions (P < 0.05). Intranodular enhancement appearing at arterial phase and decreasing at portal venous phase was considered characteristic for malignancy. Intranodular enhancement did not appear earlier than the liver parenchyma, and peripheral enhancement pattern was regarded as positive findings for hemangioma. Intranodular enhancement appeared in the arterial phase, and homogenous enhancement pattern sustained in the whole portal venous phase were regarded as positive findings for focal nodular hyperplasia. No microbubble signals appeared in two inflammatory pseudotumors of the liver.CONCLUSION: C-cube gray scale sonography can demonstrate dynamic intranodular enhancement in various focal hepatic lesions. The information provided by this methodology may be useful in the differential diagnosis of hepatic lesions.
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2003年第8期1667-1674,共8页 世界胃肠病学杂志(英文版)
  • 相关文献

参考文献20

  • 1Calliada F, Campani R, Bottinelli O, Bozzini A, Sommaruga MG. Ultrasound contrast agents basic principles. Eur J Radiol 1998, 27(Suppl): S157-S160.
  • 2Kono Y, Moriyasu F, Mine Y, Nada T, Kamiyama N, Suginoshita Y, Matsumura T, Kobayashi K, Chiba T. Gray-scale second harmonic imaging of the liver with galactose-based microbubbles.Invest Radiol 1997; 32:120-125.
  • 3Choi BI, Kim TK, Han JK, Kim AY, Seong CK, Park SJ. Vascularity of hepatocellular carcinoma: assessment with contrast-enhanced second-harmonic versus conventional power Doppler US.Radioloy 2000; 214:381-386.
  • 4Wilson SR, Burns PN, Muradali D, Wilson JA, Lai X. Harmonic hepatic US with microbubble contrast agent: initial experience showing improved characterization of hemangioma, hepatocellular carcinoma, and metastasis. Radiology 2000; 215:153-161.
  • 5Maresca G, Summaria V, Colagrande C, Manfredi R, Calliada F.New prospects for ultrasound contrast agents. Eur J Radiol 1998;27(Suppl): S171-S178.
  • 6Hosoki T, Mitomo M, Chor S, Miyahara N, Ohtani M, Morimoto K. Visualization of tumor vessels in hepatocellular carcinoma.Power Doppler compared with color Doppler and angiography.Acta Radiol 1997; 38:422-427.
  • 7Blomley MJ, Albrecht T, Cosgrove DO, Jayaram V, Eckersley RJ,Patel N, Taylor-Robinson S, Bauer A, Schlief R. Liver vascular transit time analyzed with dynamic hepatic venography with bolus injections of an US contrast agent: early experience in seven patients with metastases. Radiology 1998; 209:862-866.
  • 8Albrecht T, Blomley MJ, Cosgrove DO, Taylor-Robinson SD,Jayaram V, Eckersley R, Urbank A, Buffer-Barnes J, Patel N. Noninvasive diagnosis of hepatic cirrhosis by transit-time analysis of an ultrasound contrast agent. Lancet 1999; 353:1579-1583.
  • 9Bang N, Nielsen MB, Rasmussen AN, Osterhammel PA, Pedersen JF. Hepatic vein transit time of an ultrasound contrast agent: simplified procedure using pulse inversion imaging. Br J Radiol 2001;74:752-755.
  • 10Kim T, Murakami T, Takahashi S, Tsuda K, Tomoda K, Narumi Y, Oi H, Sakon M, Nakamura H. Optimal phases of dynamic CT for detecting hepatocellular carcinoma: evaluation of unenhanced and triple-phase images. Abdom Imaging 1999; 24:473-480.

同被引文献141

引证文献8

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部